A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer resistant to S-1.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 May 2016
At a glance
- Drugs Cisplatin (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms TRICS
- 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.
- 28 Sep 2012 Interim tolerability analysis presented at the 37th Congress of the European Society for Medical Oncology.
- 28 Sep 2012 Status changed from recruiting to active, no longer recruiting.